10 May 2013 — KAIT 8 Perdue Kidd & Vickery Wins First Humira Trial - Abbott Laboratories To Pay $2.24 Million
Today, a Cook County jury entered a verdictfinding Abbott Laboratories negligent and ordering it to pay $2,244,063.20 to Plaintiff Milton Tietz on behalf of his wife, Delores Tietz. The court en...

29 Apr 2013 — Roll Call Abbott Laboratories Employee PAC Hit by Fraud
The Abbott Laboratories Employee PAC reported it has been hit with a series of instances of fraud during the first quarter amounting to $16,102. The PAC stated (see page six) an unknown individu...

28 Apr 2013 — Seeking Alpha Abbott Is A Solid Long-Term Investment
ByIAEResearch:At the start of the year, Abbott Laboratories (ABT) completed its separation with the research based pharmaceutical business into a separate publicly traded company, called AbbVie ...

26 Apr 2013 — Lake County News Sun North Chicago hopes to halt rising water rates
North Chicago residents may see some relief on their rising water bills thanks to Abbott Laboratories spinoff of AbbVie, a move that will keep the companys fermentation plant on Sheridan Road in...

19 Apr 2013 — Reuters UPDATE 1-Russia rejects Abbott Laboratories' plan to buy Petrovax
MOSCOW, April 19 (Reuters) - Russia's government commission on foreign investment has turned down U.S. group Abbott Laboratories' request to buy Russian vaccine maker Petrovax, the head of Russi...

19 Apr 2013 — Reuters Russia rejects Abbott Laboratories' plan to buy Petrovax
MOSCOW, April 19 (Reuters) - Russia's government commission on foreign investment has rejected U.S. Abbott Laboratories' plan to buy Russian pharmaceutical producer Petrovax, the head of the Rus...

17 Apr 2013 — The Republic Abbott 1Q profit down, but adjusted results grow
NORTH CHICAGO, Illinois - Abbott Laboratories said Wednesday its first-quarter net income slid as the year-earlier period got a boost from discontinued operations. However, earnings from continu...

17 Apr 2013 — RTTNews Abbott Q1 Earnings From Continuing Operations Up 55%, Backs Full-year Outlook
Healthcare company Abbott Laboratories on Wednesday reported a 55 percent surge in earnings from continuing operations for the first quarter, reflecting strong performance in the company's nutri...

17 Apr 2013 — The Wall Street Journal Abbott's Profit Drops on Spinoff
Abbott Laboratories' first-quarter net profit fell 56% as the year-earlier period included contributions from its former research-based pharmaceutical business, while performance at its remainin...

17 Apr 2013 — RTTNews Abbott Labs Reports Q1 Profit Growth; Backs FY Earnings View - Quick Facts
Diversified healthcare company Abbott Laboratories (ABT) reported first quarter net earnings from continuing operations of $544 million or $0.34 per share, up from $351 million or $0.22 per shar...

17 Apr 2013 — Reuters UPDATE 1-Abbott Laboratories posts strong growth
April 17 (Reuters) - Abbott Laboratories reported higher earnings from continuing operations, as demand for its nutritional and diagnostic products offset declining sales of the company's medica...

17 Apr 2013 — Reuters Abbott Laboratories posts strong growth
April 17 (Reuters) - Abbott Laboratories' quarterly earnings from continuing operations were roughly in line with Wall Street forecasts, rising sharply on demand for the company's nutritional an...

17 Apr 2013 — 24/7 Wall St. Abbott Labs Earnings: A Mixed Report
Abbott Laboratories (NYSE: ABT) reported first-quarter 2013 results before markets opened this morning. The drugmaker reported adjusted diluted earnings per share (EPS) of $0.42 on revenues of $...

15 Apr 2013 — Examiner.com Blood glucose meters recalled over inaccurate reading risk
If use blood glucose meters make sure they are not part of a recall announced Monday.Abbott Laboratories is recalling its FreeStyle InsuLinx Blood Glucose Meters after discovering that they show...

15 Apr 2013 — Lake County News Sun Abbott Labs recalls FreeStyle InsuLinx blood glucose meters
Abbott Laboratories is recalling its FreeStyle InsuLinx Blood Glucose Meters after finding that they display and store incorrect test results for dangerously high blood sugar levels. The company...